Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Secale cereale allergens are proteins from rye (Secale cereale) pollen and grain that trigger IgE-mediated allergic reactions, primarily in respiratory and food allergy contexts. Key pollen allergens include those at 28 kDa, 33 kDa, 48 kDa, and 67 kDa, with Sec c 5 (group 5 grass pollen allergen) and Sec c 4 identified specifically; grain allergens feature secalins like Sec c 38 (γ-secalin) and Sec c 20, which are prolamins resistant to digestion. These allergens cause conditions such as allergic rhinitis from pollen inhalation, baker's asthma from flour exposure, and food allergies including anaphylaxis, often via cross-reactivity with wheat gliadins, barley hordeins, and grass pollens. No therapeutic drugs target these allergens for modulation; instead, pollen extracts are used solely for diagnostic allergy testing via skin prick or intradermal routes. Processing like fermentation may reduce but not eliminate allergenicity due to protein stability. Overall, they represent environmental and occupational allergens rather than druggable therapeutic targets.
Diagnostic allergen for skin prick testing and IgE detection (no therapeutic drugs target for modulation)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Secale cereale allergens.